Page last updated: 2024-10-31

nafamostat and Ascites

nafamostat has been researched along with Ascites in 1 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Ascites: Accumulation or retention of free fluid within the peritoneal cavity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyasaka, Y1
Ono, K1
Nagayama, K1
Murakami, T1
Noguchi, O1
Uchihara, M1
Izumi, N1
Miyake, S1
Kubota, K1
Enomoto, N1
Tanaka, Y1
Marumo, F1
Sato, C1

Other Studies

1 other study available for nafamostat and Ascites

ArticleYear
[A case of pancreatic pleural effusion and ascites treated successfully with conservative measures including octreotide and nafamostat mesilate].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1996, Volume: 93, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Ascites; Benzamidines; Drug Therapy, Combination; Gastroint

1996